ArticlePediatric cardiology2016
Diagnostic Utility of Three-Dimensional Rotational Angiography in Congenital Cardiac Catheterization.
Article in Pediatric cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Results from an international multi-center prospective registry of cardiac catheterizations and percutaneous cardiac interventions guided with three-dimensional imaging.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026Article
- Augmented Reality Visualization of 3D Rotational Angiography in Congenital Heart Disease: A Comparative Study to Standard Computer Visualization.Pediatric cardiology · 2024Article
- Percutaneous pulmonary valve implantation guided by three-dimensional rotational angiography.International journal of cardiology. Congenital heart disease · 2024Article
- How to obtain diagnostic and procedural quality three-dimensional-rotational angiograms in congenital heart disease: Tips and tricks from a single center experience.Cardiology journal · 2021Article
- Percutaneous Pulmonary Valve Implantation.Korean circulation journal · 2020Review
- Personalized Interventions: A Reality in the Next 20 Years or Pie in the Sky.Pediatric cardiology · 2020Review
- Three-Dimensional Rotational Angiography in Pediatric Patients with Congenital Heart Disease: A Literature Review.Pediatric cardiology · 2019Review
- Cardiovascular imaging approach in pre and postoperative tetralogy of Fallot.BMC cardiovascular disorders · 2019Review
- Pros, cons and future perspectives - three questions on three dimensional guidance for cardiac catheterization in congenital heart disease.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2019Review
- Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives.Current cardiology reviews · 2019Review
- Building an Adult Congenital Heart Program: Critical Components and Important Allies.Current cardiology reports · 2018Review
- Interventional Cardiology for Congenital Heart Disease.Korean circulation journal · 2018Review
- Innovative interventional catheterization techniques for congenital heart disease.Translational pediatrics · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We evaluated the diagnostic utility of the three modalities of three-dimensional rotational angiography (3DRA): rotational angiography (RA), multiplanar reformat (MPR) and three-dimensional angiographic reconstruction (3D-R) in pediatric cardiac catheterization. The 3DRA studies were classified by anatomy of interest based on our injection protocol: pulmonary arteries (PA), aorta, cavopulmonary connection (CPC), and others. Retrospective review of 3DRA images by two reviewers for each modality was conducted with grading as inferior, similar, or superior in comparison with the diagnostic quality of fixed-plane angiography (FPA). The percentages of grades for each modality were averaged. Weighted kappa statistic was used to evaluate inter-rater reliability. In total, 114 3DRA studies were performed on 87 patients between August 2010 and March 2012. Median age was 2.7 years (1 day-48.4 years) and median weight 12.1 kg (3.6-106.5 kg). For RA: 79.4 % of the studies were of diagnostic quality and 52.2 % were superior; 3D-R: 82 % were of diagnostic quality and 65.8 % were superior; and MPR: 83.5 % were of diagnostic quality and 63 % were superior. Overall 3DRA technologies (RA, 3D-R, MPR) were of diagnostic quality or better in 111/114 (97.4 %) studies and 103/114 (90.4 %) were judged superior. Most common reasons for inferior grading were limited opacification and metallic artifact. In pediatric cardiac catheterization, 3DRA imaging was of diagnostic quality and frequently provided additional clinically relevant data when compared to FPA.
Indexed as
Identifiers
27278632What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.